Advertisement
YOU ARE HERE: LAT HomeCollectionsDisease
IN THE NEWS

Disease

WORLD
April 7, 2010 | By Chris Kraul
Standing amid hundreds of African oil palms, their gray and desiccated fronds drooping to the ground, Edgar Barrera shakes his head and speaks of their death sentence. "What we have is a technological disaster, an economic disaster and a social disaster," said Barrera, superintendent of the Bucarelia company's 12,000-acre African palm grove. Barrera is referring to a mysterious, fast-spreading and deadly disease called "PC" that has devastated African palm plantations here in the Magdalena River valley area 200 miles north of Bogota, the capital, and elsewhere in Colombia.
Advertisement
NEWS
April 3, 1988
Learning how to drink is of no use to an alcoholic. Learning how to live is. To Fingarette, I have this to say: Please stop trying to help us, for in actuality, you are helping to kill us, and we can do that well enough on our own. ROBIN S. HECKLE Los Angeles
NEWS
April 12, 2011 | By Melissa Healy, Los Angeles Times
CALIFORNIA | LOCAL
February 9, 2008 | Patrick McGreevy
Having been absent from the Legislature for nearly two weeks, State Assemblywoman Sharon Runner (R-Lancaster) said through a spokeswoman Friday that she has been diagnosed with a rare but manageable disease that affects her autoimmune system. Runner, best known as an author of the state law requiring tracking of sex offenders, has been diagnosed with limited scleroderma, which normally affects the skin, but in her case has also caused lung problems, said spokeswoman Kayla Garcia. As a result, when the 53-year-old lawmaker catches a cold, the effects on her breathing can be more severe.
NEWS
April 13, 2011 | By Marissa Cevallos, HealthKey, Los Angeles Times Staff Writer
In the world of “promising” multiple sclerosis drugs, it’s been quite a week. Two more experimental drugs -- both in pill form, not injected -- are joining the race of new treatments to slow the disease.  A study of multiple sclerosis patients who took the drug laquinimod over two years had 23% fewer relapses -- an attack of new symptoms or worsening of old ones -- compared with patients who took a sugar pill. The group that received the drug also had a 36% reduction in disability progression and a 33% reduction in brain atrophy.
NEWS
October 18, 2010
Doctors usually diagnose Alzheimer's disease through a combination of medical and cognitive tests along with a brain scan. New studies, even one involving family members and friends, offer the promise of making the diagnosis easier -- and maybe even earlier. An August study in the Archives of Neurology used biomarkers to correctly classify patients who had Alzheimer's disease. The study tested normal people without the disease, those with mild brain impairments and those with the disease.
NEWS
April 12, 2011 | By Jeannine Stein, Los Angeles Times
Low-intensity walking may help people with Parkinson's disease improve their gait and mobility, a new study finds. The study, presented Tuesday at the American Academy of Neurology's annual meeting in Honolulu, compared three different forms of exercise to see which was most beneficial to men and women with Parkinson's disease, which affects motor control. Researchers randomly assigned 67 people with the disease to one of three programs: a low-intensity treadmill walk for 50 minutes; a high-intensity treadmill walk for 30 minutes; and a weight and stretching regimen that included leg presses, extensions and curls.
NEWS
September 26, 2011 | By Jeannine Stein, Los Angeles Times / For the Booster Shots blog
Men who don't have children may be at higher risk for cardiovascular disease, a study finds. The study, released Monday in the journal Human Reproduction , followed 137,903 male married or previously married AARP members for an average of about 10 years. At the beginning of the study, the participants, whose average age was about 63, had no history of heart disease, and 92% had fathered at least one child. Half had three or more children. During the course of the study, 3,082 men died due to cardiovascular causes.
NEWS
February 7, 2011 | By Thomas H. Maugh II
A Boston researcher will receive a $1-million prize from the Prize4Life foundation's ALS Biomarker Challenge, an effort to develop new ways to monitor the progression of amyotrophic lateral sclerosis to make it easier to test potential drugs for the disease. The prize is believed to be the biggest-ever challenge award related to a medical condition, but Prize4Life estimates it could halve the cost of clinical trials for new ALS drugs. Dr. Seward Rutkove of Beth Israel Deaconess Medical Center will receive the award formally in June.
Los Angeles Times Articles
|